Citations (71)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Tram Tran & Khary K. Rigg. (2023) Substance use among methadone patients in Vietnam: a systematic review. Journal of Substance Use 0:0, pages 1-11.
Read now
Read now
Philippe Pfeifer, Natalie Nigg-Trawally, Christine Bartsch & Thomas Reisch. (2021) Characteristics of Suicides and Toxicology in a Cohort of Individuals With Opioid Use Disorder. Archives of Suicide Research 25:2, pages 287-296.
Read now
Read now
Markus Backmund, Kirsten Meyer, Christian Schütz & Jens Reimer. (2011) Factors Associated With Suicide Attempts Among Injection Drug Users. Substance Use & Misuse 46:12, pages 1553-1559.
Read now
Read now
SarahE. Wakeman, SarahE. Bowman, Michelle McKenzie, Alexandra Jeronimo & JosiahD. Rich. (2009) Preventing Death Among the Recently Incarcerated: An Argument for Naloxone Prescription Before Release. Journal of Addictive Diseases 28:2, pages 124-129.
Read now
Read now
Zsolt Demetrovics. (2009) Co-morbidity of drug addiction: An analysis of epidemiological data and possible etiological models. Addiction Research & Theory 17:4, pages 420-431.
Read now
Read now
Yehuda D. Neumark, Michelle L. Van Etten & James C. Anthony. (2000) “Drug Dependencexy2 and Death: Survival Analysis of the Baltimore ECA Sample from 1981 to 1995. Substance Use & Misuse 35:3, pages 313-327.
Read now
Read now
Anna Fugelstad, Gunnar Agren & Anders Romelsjö. (1998) Changes in Mortality, Arrests, and Hospitalizations in Nonvoluntary Treated Heroin Addicts in Relation to Methadone Treatment. Substance Use & Misuse 33:14, pages 2803-2817.
Read now
Read now
Caroline Adamsson Wahren, Peter Allebeck & Jovan Rajs. (1997) Unnatural Causes of Death among Drug Addicts in Stockholm: An Analysis of Health Care and Autopsy Records. Substance Use & Misuse 32:14, pages 2163-2183.
Read now
Read now
Arthur Marx, Manuel Tomas Schick & Christoph E. Minder. (1994) Drug-Related Mortality in Switzerland from 1987 to 1989 in Comparison to Other Countries. International Journal of the Addictions 29:7, pages 837-860.
Read now
Read now
Articles from other publishers (62)
Dana Busschots, Erwin Ho, Sarah Blach, Frederik Nevens, Homie Razavi, Brieuc Van Damme, Thomas Vanwolleghem & Geert Robaeys. (2022) Ten years countdown to hepatitis C elimination in Belgium: a mathematical modeling approach. BMC Infectious Diseases 22:1.
Crossref
Crossref
Mawuena Binka, Naveed Z. Janjua, Jason Grebely, Chris Estes, Dena Schanzer, Jisoo A. Kwon, Naglaa H. Shoukry, Jeffrey C. Kwong, Homie Razavi, Jordan J. Feld & Mel Krajden. (2020) Assessment of Treatment Strategies to Achieve Hepatitis C Elimination in Canada Using a Validated Model. JAMA Network Open 3:5, pages e204192.
Crossref
Crossref
Helena Rontziokos & Frank Deane. (2018) Systematic Review of Suicidal Behaviour in Individuals Who Have Attended Substance Abuse Treatment. International Journal of Mental Health and Addiction 17:6, pages 1580-1598.
Crossref
Crossref
Soňa Fraňková, Petr Urbánek, Petr Husa, Vratislav Němeček, Homie Razavi, Devin Razavi-Shearer, Roman Chlíbek & Jan Šperl. (2019) Chronic hepatitis C in the Czech Republic: Forecasting the disease burden. Central European Journal of Public Health 27:2, pages 93-98.
Crossref
Crossref
Katharina Siegl, Markus M. Luedi, Pantelis Vassiliu, Peter Kauf, Ralph Schneider, Elias Degiannis & Dietrich Doll. (2018) Injury Patterns and Emergency Department Mortality After Unsuccessful Suicide. A Descriptive Study of a Consecutive Case Series. International Surgery 103:5-6, pages 280-286.
Crossref
Crossref
H. L. Y. Chan, C. J. Chen, O. Omede, J. Al Qamish, K. Al Naamani, A. Bane, S. S. Tan, M. Simonova, I. Cardenas, M. Derbala, O. Akin, R. O. Phillips, M. K. Abdelmageed, M. Abdulla, D. Adda, A. Al Baqali, N. Al Dweik, K. Al Ejji, I. Al ghazzawi, S. Al Kaabi, M. Al Sadadi, J. Al Salman, M. AlBadri, S. A. Al-Busafi, H. E. Al-Romaihi, W. Ampofo, K. Antonov, C. Anyaike, F. Arome, S. Blach, M. M. Borodo, S. M. Brandon, B. Bright, M. T. Butt, D. S. Chen, P. J. Chen, R. N. Chien, W. L. Chuang, D. Cuellar, A. A. Elbardiny, C. Estes, E. Farag, J. Fung, I. Gamkrelidze, V. Garcia, J. Genov, Z. Ghandour, M. Ghuloom, B. Gomez, J. Gunter, J. Habeeb, O. Hajelssedig, W. Hamoudi, S. M. Himatt, I. Hrstic, C. C. Hu, C. F. Huang, Y. T. Hui, R. Jahis, D. Jelev, A. K. John, K. S. Kaliaskarova, Y. Kamel, J. H. Kao, J. Khamis, H. Khattabi, I. Khoudri, A. Konysbekova, I. Kotzev, M. S. Lai, W. C. Lao, J. Layden, M. H. Lee, O. Lesi, M. Li, A. Lo, C. K. Loo, B. Lukšić, A. Maaroufi, A. O. Malu, L. Mateva, R. Mitova, R. Mohamed, M. Morović, K. Murphy, B. Mustapha, A. Nersesov, E. Ngige, R. Njouom, O. Njoya, D. Nonković, S. Obekpa, S. Oguche, E. E. Okolo, C. Omuemu, P. Ondoa, O. Opare-Sem, S. Owusu-Ofori, Y. N. Prokopenko, H. Razavi, D. Razavi-Shearer, K. Razavi-Shearer, B. Redae, T. Reic, T. Rinke de Wit, C. Rios, S. Robbins, L. R. Roberts, S. J. Sanad, J. D. Schmelzer, M. Sharma, T. H. Su, K. Sultan, K. Tchernev, O. T. Y. Tsang, S. Tsang, C. Tzeuton, S. Ugoeze, B. Uzochukwu, R. Vi, A. Vince, H. U. Wani, V. W. S. Wong, A. Workneh, R. Yacoub, K. I. Yesmembetov, M. Youbi, M. F. Yuen & H. Nde. (2017) The present and future disease burden of hepatitis C virus infections with today's treatment paradigm: Volume 4. Journal of Viral Hepatitis 24, pages 25-43.
Crossref
Crossref
Sandra M. Meier, Søren Dalsgaard, Preben B. Mortensen, James F. Leckman & Kerstin J. Plessen. (2017) Mortality risk in a nationwide cohort of individuals with tic disorders and with tourette syndrome. Movement Disorders 32:4, pages 605-609.
Crossref
Crossref
Ilias Gountas, Vana Sypsa, George Papatheodoridis, George Souliotis, Homie Razavi & Angelos Hatzakis. (2017) Is elimination of HCV possible in a country with low diagnostic rate and moderate HCV prevalence?: The case of Greece. Journal of Gastroenterology and Hepatology 32:2, pages 466-472.
Crossref
Crossref
Behzad Hajarizadeh, Jason Grebely, Hamish McManus, Chris Estes, Homie Razavi, Richard T Gray, Maryam Alavi, Janaki Amin, Skye McGregor, William Sievert, Alexander Thompson & Gregory J Dore. (2017) Chronic hepatitis C burden and care cascade in Australia in the era of interferon-based treatment. Journal of Gastroenterology and Hepatology 32:1, pages 229-236.
Crossref
Crossref
Oliver G. Bosch & Erich Seifritz. (2016) The behavioural profile of gamma-hydroxybutyrate, gamma-butyrolactone and 1,4-butanediol in humans. Brain Research Bulletin 126, pages 47-60.
Crossref
Crossref
Dayong Lee, Chris Delcher, Mildred M. Maldonado-Molina, Jon R. Thogmartin & Bruce A. Goldberger. (2016) Manners of Death in Drug-Related Fatalities in Florida. Journal of Forensic Sciences 61:3, pages 735-742.
Crossref
Crossref
Linda B. CottlerHui HuBryan A. SmallwoodJames C. AnthonyLi-Tzy WuWilliam W. Eaton. (2016) Nonmedical Opioid Pain Relievers and All-Cause Mortality: A 27-Year Follow-Up From the Epidemiologic Catchment Area Study. American Journal of Public Health 106:3, pages 509-516.
Crossref
Crossref
Ezequiel Ridruejo, Fernando Bessone, Jorge R Daruich, Chris Estes, Adrián C Gadano, Homie Razavi, Federico G Villamil & Marcelo O Silva. (2016) Hepatitis C virus infection in Argentina: Burden of chronic disease. World Journal of Hepatology 8:15, pages 649.
Crossref
Crossref
Jodi M. Gatley & Russell C. Callaghan. 2016. Neuropathology of Drug Addictions and Substance Misuse. Neuropathology of Drug Addictions and Substance Misuse
104
114
.
Anneli Uusküla, Mait Raag, Sigrid Vorobjov, Kristi Rüütel, Alexandra Lyubimova, Olga S. Levina & Robert Heimer. (2015) Non-fatal overdoses and related risk factors among people who inject drugs in St. Petersburg, Russia and Kohtla-Järve, Estonia. BMC Public Health 15:1.
Crossref
Crossref
A. Sibley, K. H. Han, A. Abourached, L. A. Lesmana, M. Makara, W. Jafri, R. Salupere, A. M. Assiri, A. Goldis, F. Abaalkhail, Z. Abbas, A. Abdou, F. Al Braiki, F. Al Hosani, K. Al Jaberi, M. Al Khatry, M. A. Al Mulla, H. Al Quraishi, A. Al Rifai, Y. Al Serkal, A. Alam, S. M. Alavian, H. I. Alashgar, S. Alawadhi, L. Al‐Dabal, P. Aldins, F. Z. Alfaleh, A. S. Alghamdi, R. Al‐Hakeem, A. A. Aljumah, A. Almessabi, A. N. Alqutub, K. A. Alswat, I. Altraif, M. Alzaabi, N. Andrea, M. A. Babatin, A. Baqir, M. T. Barakat, O. M. Bergmann, A. R. Bizri, S. Blach, A. Chaudhry, M. S. Choi, T. Diab, S. Djauzi, E. S. El Hassan, S. El Khoury, C. Estes, S. Fakhry, J. I. Farooqi, H. Fridjonsdottir, R. A. Gani, A. Ghafoor Khan, L. Gheorghe, M. Gottfredsson, S. Gregorcic, J. Gunter, B. Hajarizadeh, S. Hamid, I. Hasan, A. Hashim, G. Horvath, B. Hunyady, R. Husni, A. Jeruma, J. G. Jonasson, B. Karlsdottir, D. Y. Kim, Y. S. Kim, Z. Koutoubi, V. Liakina, Y. S. Lim, A. Löve, M. Maimets, R. Malekzadeh, M. Matičič, M. S. Memon, S. Merat, J. E. Mokhbat, F. H. Mourad, D. H. Muljono, A. Nawaz, N. Nugrahini, S. Olafsson, S. Priohutomo, H. Qureshi, P. Rassam, H. Razavi, D. Razavi‐Shearer, K. Razavi‐Shearer, B. Rozentale, M. Sadik, K. Saeed, A. Salamat, F. M. Sanai, A. Sanityoso Sulaiman, R. A. Sayegh, A. I. Sharara, M. Siddiq, A. M. Siddiqui, G. Sigmundsdottir, B. Sigurdardottir, D. Speiciene, A. Sulaiman, M. A. Sultan, M. Taha, J. Tanaka, H. Tarifi, G. Tayyab, I. Tolmane, M. Ud din, M. Umar, J. Valantinas, J. Videčnik‐Zorman, C. Yaghi, E. Yunihastuti, M. A. Yusuf, B. F. Zuberi & J. D. Schmelzer. (2015) The present and future disease burden of hepatitis C virus infections with today's treatment paradigm – volume 3. Journal of Viral Hepatitis 22:S4, pages 21-41.
Crossref
Crossref
Paulo Roberto Abrão Ferreira, Carlos Eduardo Brandão-Mello, Chris Estes, Fernando Lopes Gonçales Júnior, Henrique Sérgio Moraes Coelho, Homie Razavi, Hugo Cheinquer, Fernando Herz Wolff, Maria Lúcia Gomes Ferraz, Mário Guimarães Pessoa & Maria Cássia Mendes-Correa. (2015) Disease burden of chronic hepatitis C in Brazil. The Brazilian Journal of Infectious Diseases 19:4, pages 363-368.
Crossref
Crossref
A. Hatzakis, V. Chulanov, A. C. Gadano, C. Bergin, Z. Ben-Ari, J. Mossong, I. Schréter, O. Baatarkhuu, S. Acharya, I. Aho, A. C. Anand, M. I. Andersson, V. Arendt, P. Arkkila, K. Barclay, F. Bessone, S. Blach, N. Blokhina, C. R. Brunton, G. Choudhuri, L. Cisneros, E. A. Croes, Y. A. Dahgwahdorj, O. Dalgard, J. R. Daruich, N. R. Dashdorj, D. Davaadorj, R. J. de Knegt, M. de Vree, C. Estes, R. Flisiak, E. Gane, E. Gower, W. Halota, C. Henderson, P. Hoffmann, J. Hornell, D. Houlihan, S. Hrusovsky, P. Jarčuška, D. Kershenobich, K. Kostrzewska, P. Kristian, M. Leshno, Y. Lurie, A. Mahomed, N. Mamonova, N. Mendez-Sanchez, S. Norris, E. Nurmukhametova, P. Nymadawa, M. Oltman, J. Oyunbileg, Ts. Oyunsuren, G. Papatheodoridis, N. Pimenov, N. Prabdial-Sing, M. Prins, S. Radke, A. Rakhmanova, K. Razavi-Shearer, H. W. Reesink, E. Ridruejo, R. Safadi, O. Sagalova, J. F. Sanchez Avila, R. Sanduijav, V. Saraswat, C. Seguin-Devaux, S. R. Shah, I. Shestakova, A. Shevaldin, O. Shibolet, M. O. Silva, S. Sokolov, M. Sonderup, K. Souliotis, C. W. Spearman, T. Staub, C. Stedman, E. A. Strebkova, D. Struck, V. Sypsa, K. Tomasiewicz, L. Undram, A. J. van der Meer, D. van Santen, I. Veldhuijzen, F. G. Villamil, S. Willemse, E. Zuckerman, F. R. Zuure, P. Puri & H. Razavi. (2015) The present and future disease burden of hepatitis C virus (HCV) infections with today's treatment paradigm - volume 2. Journal of Viral Hepatitis 22, pages 26-45.
Crossref
Crossref
Robert Flisiak, Waldemar Halota, Krzysztof Tomasiewicz, Kaja Kostrzewska, Homie A. Razavi & Erin E. Gower. (2015) Forecasting the disease burden of chronic hepatitis C virus in Poland. European Journal of Gastroenterology & Hepatology 27:1, pages 70-76.
Crossref
Crossref
William Sievert, Homie Razavi, Chris Estes, Alexander J Thompson, Amany Zekry, Stuart K Roberts & Gregory J Dore. (2014) Enhanced antiviral treatment efficacy and uptake in preventing the rising burden of hepatitis C-related liver disease and costs in Australia. Journal of Gastroenterology and Hepatology 29, pages 1-9.
Crossref
Crossref
H. Razavi, I. Waked, C. Sarrazin, R. P. Myers, R. Idilman, F. Calinas, W. Vogel, M. C. Mendes Correa, C. Hézode, P. Lázaro, U. Akarca, S. Aleman, İ. Balık, T. Berg, F. Bihl, M. Bilodeau, A. J. Blasco, C. E. Brandão Mello, P. Bruggmann, M. Buti, J. L. Calleja, H. Cheinquer, P. B. Christensen, M. Clausen, H. S. M. Coelho, M. E. Cramp, G. J. Dore, W. Doss, A. S. Duberg, M. H. El-Sayed, G. Ergör, G. Esmat, K. Falconer, J. Félix, M. L. G. Ferraz, P. R. Ferreira, S. Frankova, J. García-Samaniego, J. Gerstoft, J. A. Giria, F. L. GonçalesJrJr, E. Gower, M. Gschwantler, M. Guimarães Pessôa, S. J. Hindman, H. Hofer, P. Husa, M. Kåberg, K. D. E. Kaita, A. Kautz, S. Kaymakoglu, M. Krajden, H. Krarup, W. Laleman, D. Lavanchy, R. T. Marinho, P. Marotta, S. Mauss, C. Moreno, K. Murphy, F. Negro, V. Nemecek, N. Örmeci, A. L. H. Øvrehus, J. Parkes, K. Pasini, K. M. Peltekian, A. Ramji, N. Reis, S. K. Roberts, W. M. Rosenberg, F. Roudot-Thoraval, S. D. Ryder, R. Sarmento-Castro, D. Semela, M. Sherman, G. E. Shiha, W. Sievert, J. Sperl, P. Stärkel, R. E. Stauber, A. J. Thompson, P. Urbanek, P. Van Damme, I. van Thiel, H. Van Vlierberghe, D. Vandijck, H. Wedemeyer, N. Weis, J. Wiegand, A. Yosry, A. Zekry, M. Cornberg, B. Müllhaupt & C. Estes. (2014) The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm. Journal of Viral Hepatitis 21, pages 34-59.
Crossref
Crossref
Wayne A. Bowers. 2014. Eating Disorders, Addictions and Substance Use Disorders. Eating Disorders, Addictions and Substance Use Disorders
649
664
.
P. Mannelli, L.-T. Wu, K. S. Peindl & D. A. Gorelick. (2013) Smoking and Opioid Detoxification: Behavioral Changes and Response to Treatment. Nicotine & Tobacco Research 15:10, pages 1705-1713.
Crossref
Crossref
Yu Liu, Nicholas Bartlett, Longhui Li, Xiuyi Lv, Yahai Zhang & Wenhua Zhou. (2012) Attitudes and knowledge about naloxone and overdose prevention among detained drug users in Ningbo, China. Substance Abuse Treatment, Prevention, and Policy 7:1.
Crossref
Crossref
Ingrid Davstad, Peter Allebeck, Anders Leifman, Marlene Stenbacka & Anders Romelsjö. (2011) Self-reported drug use and mortality among a nationwide sample of Swedish conscripts – A 35-year follow-up. Drug and Alcohol Dependence 118:2-3, pages 383-390.
Crossref
Crossref
SHANE DARKE. (2010) The toxicology of homicide offenders and victims: A review. Drug and Alcohol Review 29:2, pages 202-215.
Crossref
Crossref
MARLENE STENBACKA, ANDERS LEIFMAN & ANDERS ROMELSJÖ. (2009) Mortality and cause of death among 1705 illicit drug users: A 37 year follow up. Drug and Alcohol Review 29:1, pages 21-27.
Crossref
Crossref
Walter Cullen, Sarah O'Brien, Austin O'Carroll, Fergus D O'Kelly & Gerard Bury. (2009) Chronic illness and multimorbidity among problem drug users: a comparative cross sectional pilot study in primary care. BMC Family Practice 10:1.
Crossref
Crossref
MARK A. STOOVÉ, PAUL M. DIETZE & DAMIEN JOLLEY. (2009) Overdose deaths following previous non-fatal heroin overdose: Record linkage of ambulance attendance and death registry data. Drug and Alcohol Review 28:4, pages 347-352.
Crossref
Crossref
Alexander K. Elkader, Bruna Brands, Peter Selby & Beth A. Sproule. (2009) Methadone-Nicotine Interactions in Methadone Maintenance Treatment Patients. Journal of Clinical Psychopharmacology 29:3, pages 231-238.
Crossref
Crossref
Kelly E. Dunn, Stacey C. Sigmon, Edward Reimann, Sarah H. Heil & Stephen T. Higgins. (2009) Effects of Smoking Cessation on Illicit Drug Use among Opioid Maintenance Patients: A Pilot Study. Journal of Drug Issues 39:2, pages 313-327.
Crossref
Crossref
Kelly E. Dunn, Stacey C. Sigmon, Colleen S. Thomas, Sarah H. Heil & Stephen T. Higgins. (2013) VOUCHER‐BASED CONTINGENT REINFORCEMENT OF SMOKING ABSTINENCE AMONG METHADONE‐MAINTAINED PATIENTS: A PILOT STUDY. Journal of Applied Behavior Analysis 41:4, pages 527-538.
Crossref
Crossref
Uberto Gatti, Richard E. Tremblay & Hans M. A. Schadee. (2007) Community Characteristics and Death by Homicide, Suicide and Drug Overdose in Italy: The Role of Civic Engagement. European Journal on Criminal Policy and Research 13:3-4, pages 255-275.
Crossref
Crossref
Stacey C. Sigmon. (2007) Investigating the pharmacological and nonpharmacological factors that modulate drug reinforcement.. Experimental and Clinical Psychopharmacology 15:1, pages 1-20.
Crossref
Crossref
Marcelo Ribeiro, John Dunn, Ricardo Sesso, Andréa Costa Dias & Ronaldo Laranjeira. (2006) Causes of death among crack cocaine users. Revista Brasileira de Psiquiatria 28:3, pages 196-202.
Crossref
Crossref
Michael D. Stein, Marjorie C. Weinstock, Debra S. Herman, Bradley J. Anderson, Jennifer L. Anthony & Raymond Niaura. (2006) A smoking cessation intervention for the methadone‐maintained. Addiction 101:4, pages 599-607.
Crossref
Crossref
Anna Maria Bargagli, Matthew Hickman, Marina Davoli, Carlo A. Perucci, Patrizia Schifano, Marcel Buster, Teresa Brugal & Julian Vicente. (2006) Drug-related mortality and its impact on adult mortality in eight European countries. European Journal of Public Health 16:2, pages 198-202.
Crossref
Crossref
Robert W. Watson. 2006. Brackenridge’s Medical Selection of Life Risks. Brackenridge’s Medical Selection of Life Risks
873
894
.
Robert W Watson. 2006. Brackenridge’s Medical Selection of Life Risks. Brackenridge’s Medical Selection of Life Risks
873
894
.
Jennifer E. Johnson, John W. Finney & Rudolf H. Moos. (2005) Predictors of 5-year mortality following inpatient/residential group treatment for substance use disorders. Addictive Behaviors 30:7, pages 1300-1316.
Crossref
Crossref
Shane Darke & Joanne Ross. (2002) Suicide among heroin users: rates, risk factors and methods. Addiction 97:11, pages 1383-1394.
Crossref
Crossref
Steve Shoptaw, Erin Rotheram‐Fuller, Xiaowei Yang, Dominick Frosch, Debbie Nahom, Murray E. Jarvik, Richard A. Rawson & Walter Ling. (2002) Smoking cessation in methadone maintenance. Addiction 97:10, pages 1317-1328.
Crossref
Crossref
Marcel C. A. Buster, Giel H. A. van Brussel & Wim van den Brink. (2002) An increase in overdose mortality during the first 2 weeks after entering or re‐entering methadone treatment in Amsterdam. Addiction 97:8, pages 993-1001.
Crossref
Crossref
Dominick L. Frosch, Judith A. Stein & Steve Shoptaw. (2002) Using latent-variable models to analyze smoking cessation clinical trial data: An example among the methadone maintained.. Experimental and Clinical Psychopharmacology 10:3, pages 258-267.
Crossref
Crossref
Michael Gossop, Duncan Stewart, Samantha Treacy & John Marsden. (2002) A prospective study of mortality among drug misusers during a 4‐year period after seeking treatment. Addiction 97:1, pages 39-47.
Crossref
Crossref
M.C. Grassi, A.M. Caricati, M. Intraligi, M. Buscema & P. Nencini. (2002) Artificial neural network assessment of substitutive pharmacological treatments in hospitalised intravenous drug users. Artificial Intelligence in Medicine 24:1, pages 37-49.
Crossref
Crossref
Rumi Kato Price, Nathan K. Risk, Keith S. Murray, Katherine S. Virgo & Edward L. Spitznagel. (2001) Twenty-five year mortality of US servicemen deployed in Vietnam: predictive utility of early drug use. Drug and Alcohol Dependence 64:3, pages 309-318.
Crossref
Crossref
J Neeleman. (2001) A continuum of premature death. Meta-analysis of competing mortality in the psychosocially vulnerable. International Journal of Epidemiology 30:1, pages 154-162.
Crossref
Crossref
Clare Harris & Brian Barraclough. (2018) Excess mortality of mental disorder. British Journal of Psychiatry 173:1, pages 11-53.
Crossref
Crossref
Jan Neeleman, Simon Wessely & Michael Wadsworth. (1998) Predictors of suicide, accidental death, and premature natural death in a general-population birth cohort. The Lancet 351:9096, pages 93-97.
Crossref
Crossref
Jan Neeleman & Michael Farrell. (2018) Suicide and substance misuse. British Journal of Psychiatry 171:4, pages 303-304.
Crossref
Crossref
A. Fugelstad, A. Annell, J. Rajs & G. Ågren. (2007) Mortality and causes and manner of death among drug addicts in Stockholm during the period 1981–1992. Acta Psychiatrica Scandinavica 96:3, pages 169-175.
Crossref
Crossref
MARTIN FRISCHER, DAVID GOLDBERG, MOHAMMED RAHMAN & LEE BERNEY. (2006) Mortality and survival among a cohort of drug injectors in Glasgow, 1982–1994. Addiction 92:4, pages 419-427.
Crossref
Crossref
Daniel N. Allen & Rhonda K. B. Landis. 1997. Handbook of Neuropsychology and Aging. Handbook of Neuropsychology and Aging
111
137
.
SHANE DARKE, JOANNE ROSS & WAYNE HALL. (1996) Overdose among heroin users in Sydney, Australia: I. Prevalence and correlates of non-fatal overdose. Addiction 91:3, pages 405-411.
Crossref
Crossref
SHANE DARKE, JOANNE ROSS & WAYNE HALL. (2006) Overdose among heroin users in Sydney, Australia: I. Prevalence and correlates of non‐fatal overdose. Addiction 91:3, pages 405-411.
Crossref
Crossref
Kurt M. Ribisl, Maureen A. Walton, Carol T. Mowbray, Douglas A. Luke, William S. DavidsonIIII & Bonnie J. Bootsmiller. (1996) Minimizing participant attrition in panel studies through the use of effective retention and tracking strategies: Review and recommendations. Evaluation and Program Planning 19:1, pages 1-25.
Crossref
Crossref
ANNA FUGELSTAD, JOVAN RAJS, MARGARETA BOTTIGER & MARIA GERHARDSSON VERDIER. (1995) Mortality among HIV-infected intravenous drug addicts in Stockholm in relation to methadone treatment. Addiction 90:5, pages 711-716.
Crossref
Crossref
Joy M. Schmitz, Howard Rhoades & John Grabowski. (1995) Contingent reinforcement for reduced carbon monoxide levels in methadone maintenance patients. Addictive Behaviors 20:2, pages 171-179.
Crossref
Crossref
EDNA OPPENHEIMER, CLIVE TOBUTT, COLIN TAYLOR & TOBY ANDREW. (2006) Death and survival in a cohort of heroin addicts from London clinics: a 22‐year follow‐up study. Addiction 89:10, pages 1299-1308.
Crossref
Crossref
M Davoli, F Forastiere, D D Abeni, E Rapiti & C A Perucci. (1994) Longitudinal and cross sectional mortality studies in injecting drug-users.. Journal of Epidemiology & Community Health 48:1, pages 101-101.
Crossref
Crossref
Rudolf H. Moos, Penny L. Brennan & Jennifer R. Mertens. (2006) Mortality Rates and Predictors of Mortality Among Late‐Middle‐Aged and Older Substance Abuse Patients. Alcoholism: Clinical and Experimental Research 18:1, pages 187-195.
Crossref
Crossref